References
- Sarnes E, Crofford L, Watson M, et al. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther 2011;33:1413-32
- Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken) 2013;65:294-8
- Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013;9:30
- Manson SC, Brown RE, Cerulli A, Vidaurre CF. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 2009;103:975-94
- Geisz M, Ha C, Kappelman MD, et al. Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease. Inflamm Bowel Dis 2016;22:1435-41
- Rice JB, White AG, Scarpati LM, et al. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther 2017;39:2216-29
- Shah M, Chaudhari S, McLaughlin TP, et al. Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus. Clin Ther 2013;35:486-97
- Broder MS, Sarsour K, Chang E, et al. Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis. Semin Arthritis Rheum 2016;46:246-52
- Ledford D, Broder MS, Antonova E, et al. Corticosteroid-related toxicity in patients with chronic idiopathic urticariachronic spontaneous urticaria. Allergy Asthma Proc 2016;37:458-65
- Rice J, White A, Johnson M, et al. Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population. J Med Econ 2018. doi: 10.1080/13696998.2018.1474750
- Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68:1119-24
- Farinde A. Corticosteroid Dose Equivalents. Medscape, 2016. Available at: http://emedicine.medscape.com/article/2172042-overview [Last accessed May 11, 2018]
- Drugs.com. Dexamethasone Sodium Phosphate. 2017. Available at: https://www.drugs.com/pro/dexamethasone-sodium-phosphate.html [Last accessed May 11, 2018]
- Entocort EC (budesonide) [package insert]. Södertälje, Sweden: AstraZeneca, 2009
- Chen SY, Choi CB, Li Q, et al. Glucocorticoid use in patients with systemic lupus erythematosus: association between dose and health care utilization and costs. Arthritis Care Res (Hoboken) 2015;67:1086-94
- Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
- Emamikia S, Gentline C, Chatzidionysiou K, et al. Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial. Scand J Rheumatol 2018;47:131-40
- Gheith OA, Nematalla AH, Bakr MA, et al. Cost–benefit of steroid avoidance in renal transplant patients: a prospective randomized study. Scand J Urol Nephrol 2010;44:175-82